CRISPR Market worth $6.12 billion by 2031
The report "CRISPR Market by Offering (Products [Kits, Enzymes, Libraries], Services [gRNA Synthesis, Cell Line Development, Screening, Validation]), Application (Drug Discovery, Development, Agriculture), End User, Competition, Region - Global Forecast to 2031" is expected to reach USD 6.12 billion in 2031 from USD 3.48 billion in 2026, at a CAGR of 12.0% during the forecast period.
Browse 388 market data Tables and 53 Figures spread through 319 Pages and in-depth TOC on "CRISPR Market By Offering (Products [Kits, Enzymes, Libraries], Services [gRNA Synthesis, Cell Line Development, Screening, Validation]), Application (Drug Discovery, Development, Agriculture), End User, Competition, Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/crispr-technology-market-134401204.html
The CRISPR market is experiencing significant growth, driven by the expanding use of gene editing in drug discovery and development, growing demand for CRISPR-based gene therapies, advancements in CRISPR-Cas systems, and increasing adoption of high-throughput CRISPR screening. Pharmaceutical and biotechnology companies are increasingly using CRISPR technologies for target identification, functional genomics, cell line development, and therapeutic research. The growing use of CRISPR in agriculture and advances in gRNA design and optimization are further supporting market expansion. However, the market continues to face challenges such as off-target effects, delivery limitations, technical complexities, regulatory hurdles, and concerns related to the safety and scalability of CRISPR-based applications.
By offering, the products segment held the largest share of the CRISPR market in 2025.
By offering, the CRISPR market is segmented into products and services. In 2025, products accounted for the largest market share. This is mainly due to recurring demand for CRISPR kits, enzymes, libraries, guide RNAs, and other research consumables across gene-editing workflows. Pharmaceutical and biotechnology companies, as well as academic and research institutes, use these products for gene knockout, gene activation, functional genomics, target validation, and drug discovery. The growing adoption of CRISPR-based screening and increasing gene editing research further support product consumption. Continued development of advanced Cas enzymes, optimized guide RNA solutions, and ready-to-use CRISPR kits also supports the segment's leading position.
By product type, the CRISPR kits & enzymes segment held the largest share of the CRISPR product market in 2025.
By product type, the CRISPR product market is segmented into CRISPR kits & enzymes, CRISPR libraries, and other products. In 2025, CRISPR kits & enzymes accounted for the largest market share. Their leading position is supported by their extensive use across routine gene editing, target validation, cell engineering, and functional genomics workflows. CRISPR kits provide researchers with standardized components for gene knockout, knock-in, and other genome editing experiments, while enzymes such as Cas9 and other Cas nucleases are core components of CRISPR workflows. Their broad applicability across pharmaceutical research, biotechnology R&D, and academic laboratories creates recurring demand. The availability of workflow-specific kits and improved CRISPR enzymes with enhanced editing performance further supports this segment's dominance.
By region, North America accounted for the largest share of the market in 2025.
In 2025, North America held the largest share of the CRISPR market. This is supported by strong biotechnology and pharmaceutical research activity, high investment in gene editing, and a well-established life sciences infrastructure. The US leads the region in CRISPR-based drug discovery, functional genomics, high-throughput screening, and therapeutic development. Leading CRISPR technology providers, biotechnology companies, academic research institutes, and pharmaceutical companies create strong demand for CRISPR products and services. Growing clinical development of gene-edited therapies and continued advancements in CRISPR-Cas systems, guide RNA technologies, and screening platforms further support market growth in North America.
Some of the leading players in the market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), GenScript (US), Takara Bio (Japan), Creative Biogene (US), Fujian SunyBiotech Co., Ltd. (China), EditCo (US), Caribou Biosciences, Inc. (US), and Lonza (Switzerland), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the CRISPR Market
- What will your New Revenue Sources be
- Who will be your Top Customer; what will make them switch
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
